SecSonar.com

Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Harvard Bioscience, Inc. (HBIO) is a Medical - Instruments & Supplies company based in US with a market capitalization of $26.7M. Revenue declined 8.1% year-over-year and the company generated $5.6M in free cash flow. This page tracks HBIO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 330 employees · IPO Mar 19, 2001

Valuation

Valuation & price

$5.25 · as of May 17, 2026 · -33.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.94

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$7.67$5.83$3.99Jul 25Dec 25Jul 26Jul 7, 25$4.43Jul 9, 25$4.57Jul 11, 25$4.45Jul 15, 25$3.99Jul 17, 25$4.54Jul 21, 25$4.50Jul 23, 25$5.56Jul 25, 25$5.65Jul 29, 25$5.00Jul 31, 25$4.66Aug 4, 25$4.35Aug 6, 25$5.05Aug 11, 25$4.79Aug 13, 25$5.00Aug 15, 25$5.29Aug 19, 25$4.87Aug 21, 25$4.76Aug 25, 25$5.02Aug 27, 25$5.34Aug 29, 25$4.95Sep 3, 25$4.74Sep 5, 25$4.78Sep 9, 25$4.38Sep 11, 25$4.44Sep 16, 25$4.85Sep 18, 25$4.83Sep 22, 25$4.77Sep 24, 25$4.48Sep 26, 25$4.44Sep 30, 25$4.39Oct 2, 25$4.59Oct 6, 25$4.40Oct 8, 25$4.44Oct 10, 25$4.20Oct 14, 25$4.21Oct 16, 25$4.00Oct 21, 25$4.10Oct 23, 25$4.04Oct 27, 25$4.02Oct 29, 25$4.47Oct 31, 25$5.17Nov 4, 25$6.16Nov 6, 25$5.46Nov 10, 25$5.81Nov 12, 25$6.22Nov 14, 25$6.60Nov 18, 25$6.40Nov 20, 25$5.62Nov 25, 25$7.40Nov 28, 25$7.61Dec 2, 25$7.20Dec 4, 25$7.23Dec 8, 25$7.57Dec 10, 25$7.65Dec 12, 25$7.41Dec 16, 25$7.00Dec 18, 25$7.67Dec 22, 25$7.54Dec 24, 25$7.25Dec 29, 25$6.62Jan 2, 26$6.52Jan 6, 26$6.91Jan 8, 26$6.52Jan 12, 26$6.21Jan 14, 26$5.65Jan 16, 26$5.87Jan 21, 26$5.92Jan 23, 26$5.92Jan 27, 26$5.91Jan 29, 26$5.37Feb 2, 26$5.02Feb 4, 26$5.10Feb 9, 26$5.30Feb 11, 26$5.44Feb 13, 26$5.55Feb 18, 26$5.93Feb 20, 26$5.83Feb 24, 26$5.81Feb 26, 26$6.01Mar 2, 26$5.91Mar 4, 26$5.74Mar 6, 26$5.50Mar 10, 26$5.30Mar 12, 26$4.94Mar 17, 26$4.87Mar 19, 26$5.60Mar 23, 26$5.34Mar 25, 26$5.13Mar 27, 26$4.87Mar 31, 26$4.87Apr 2, 26$5.20Apr 7, 26$5.40Apr 9, 26$5.37Apr 13, 26$4.66Apr 15, 26$5.74Apr 17, 26$6.13Apr 22, 26$6.69Apr 24, 26$6.86Apr 28, 26$6.45Apr 30, 26$6.38May 4, 26$6.40May 6, 26$7.24May 8, 26$6.90May 12, 26$5.41May 14, 26$5.52May 18, 26$5.00May 20, 26$5.40May 22, 26$5.59May 28, 26$5.95Jun 1, 26$6.40Jun 3, 26$6.50Jun 5, 26$6.20Jun 9, 26$6.04Jun 11, 26$6.64Jun 15, 26$5.99Jun 17, 26$6.00Jun 22, 26$6.06Jun 24, 26$6.08Jun 26, 26$6.04Jul 2, 26$6.15
$3.7952-week range$7.87
Loading valuation history…

Fundamentals

Key fundamentals

$26.7M

Market cap

-8.1%

Revenue growth (YoY)

53.0%

Gross margin

$5.6M

Free cash flow (USD)

$35.7M

Net debt

2.0%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$104.5MFY 2017$101.9MFY 2018$120.8MFY 2019$116.2MFY 2020$102.1MFY 2021$118.9MFY 2022$113.3MFY 2023$112.3MFY 2024$94.1MFY 2025$86.5M
$104.5M$86.6M

Free cash flow by year

2016 → 2025

FY 2016$3.9MFY 2017$167.0KFY 2018$1.4MFY 2019$6.8MFY 2020$8.2MFY 2021$-83.0KFY 2022$-438.0KFY 2023$11.7MFY 2024$-1.8MFY 2025$5.6M
$3.9M$5.6M

Gross margin by year

2021 → 2025

FY 202156.9%FY 202253.7%FY 202358.9%FY 202458.2%FY 202553.0%
56.9%53.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventStockholder ApprovalsJun 2, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • 8-K eventDebt RefinancingMay 12, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing

Questions

Frequently asked questions

What is Harvard Bioscience, Inc.'s market cap?

Harvard Bioscience, Inc. (HBIO) has a market capitalization of $26.7M.

What is HBIO's P/E ratio?

A meaningful P/E ratio is not available for HBIO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is HBIO's price-to-book (P/B) ratio?

HBIO trades at 1.94 times book value per share.

Are insiders buying HBIO stock?

SEC Form 4 filings show no open-market insider buys at Harvard Bioscience, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Instruments & Supplies

RVP

Retractable Technologies, Inc.

$20.4M

MLSS

Milestone Scientific Inc.

$33.7M

ZJYL

Jin Medical International Ltd.

$17.6M

NEPH

Nephros, Inc.

$40.2M

FEMY

Femasys Inc.

$11.1M

POCI

Precision Optics Corporation, Inc.

$42.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.